These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15759526)

  • 41. [Spasticity. Physical therapy, preventive measures and treatment].
    Gay S; Egon G
    Ann Fr Anesth Reanim; 2005 Jun; 24(6):663-6. PubMed ID: 15950113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.
    Elia AE; Filippini G; Calandrella D; Albanese A
    Mov Disord; 2009 Apr; 24(6):801-12. PubMed ID: 19224614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of spasticity with botulinum toxin: a double-blind study.
    Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
    Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.
    Criswell SR; Crowner BE; Racette BA
    Neurosurg Focus; 2006 Aug; 21(2):e1. PubMed ID: 16918222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinal cord injury and use of botulinum toxin in reducing spasticity.
    Fried GW; Fried KM
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):901-10. PubMed ID: 14580044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Automatic EMG-guided botulinum toxin treatment of spasticity.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Jun; 20(3):195-203. PubMed ID: 9197941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A for spasticity, muscle spasms, and rigidity.
    Grazko MA; Polo KB; Jabbari B
    Neurology; 1995 Apr; 45(4):712-7. PubMed ID: 7723960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot.
    Baricich A; Carda S; Bertoni M; Maderna L; Cisari C
    J Rehabil Med; 2008 Nov; 40(10):870-2. PubMed ID: 19242626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of serial casting after botulinum toxin type A injection in improving equinovarus deformity in patients with chronic stroke.
    Yaşar E; Tok F; Safaz I; Balaban B; Yilmaz B; Alaca R
    Brain Inj; 2010; 24(5):736-9. PubMed ID: 20334469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity.
    Mills PB; Finlayson H; Sudol M; O'Connor R
    Clin Rehabil; 2016 Jun; 30(6):537-48. PubMed ID: 26198891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
    Lee JH; Sung IY; Yoo JY; Park EH; Park SR
    J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Care management of spasticity with botulinum toxin-A in patients with severe acquired brain injury: a 1-year follow-up prospective study.
    Clemenzi A; Formisano R; Matteis M; Gallinacci L; Cochi G; Savina P; Cicinelli P
    Brain Inj; 2012; 26(7-8):979-83. PubMed ID: 22571286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
    Hurvitz EA; Conti GE; Brown SH
    Arch Phys Med Rehabil; 2003 Mar; 84(3):444-54. PubMed ID: 12638115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.